How many studies have been conducted on Thromboxane B2?

BiohacksAI has indexed 300 PubMed studies on Thromboxane B2, including 9 randomized controlled trials (RCTs). 32% of studies involve human subjects.

What are the main research areas for Thromboxane B2?

The primary research domains for Thromboxane B2 are 🔬 Inflammation, ❤️ Cardiovascular, 🫘 Kidney. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thromboxane B2

A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).

300+ PubMed studies analyzed · 9 RCTs · Evidence Score: 49.1

Research Domains

Thromboxane B2 has been studied across 14 research domains including 🔬 Inflammation, ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 🧠 Focus & Attention. The primary research focus is 🔬 Inflammation with 40% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thromboxane B2 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.